CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway

References

• WeissRHMetabolomics and metabolic reprogramming in kidney cancerSemin Nephrol201838217518229602399
   PubMed Web of Science ®Google Scholar
• Pendón-Ruiz de MierMVAgüeraMLNavarroMDRodriguez-BenotAAljamaPPrevalence and survival of cancer after pancreas-kidney transplantationTransplant Proc201850266967229579884
   PubMed Web of Science ®Google Scholar
• GeYWeygantNQuDAlternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancerInt J Cancer Epub2018325
   Web of Science ®Google Scholar
• ChangWHHorngHCYehCCRisks of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease: a population-based cohort study in TaiwanMedicine20189712e015729561423
   PubMed Web of Science ®Google Scholar
• SoriaFBeleniAID’AndreaDPseudoprogression and hyper-progression during immune checkpoint inhibitor therapy for urothelial and kidney cancerWorld J Urol Epub2018316
   Web of Science ®Google Scholar
• KelseyRKidney cancer: ccrcc1–4 classification for prediction of relapseNat Rev Urol2018154205
   Google Scholar
• Torres da CostaESilvaVCostalongaECCoelhoFOCairesRABurdmannEAAssessment of kidney function in patients with cancerAdv Chronic Kidney Dis2018251495629499887
   PubMed Web of Science ®Google Scholar
• HnaskoRLisantiMPThe biology of caveolae: lessons from caveolin knockout mice and implications for human diseaseMol Interv20033844546414993453
   PubMedGoogle Scholar
• FuSJJengCJMaCHUbiquitin ligase RNF138 promotes episodic Ataxia Type 2-associated aberrant degradation of human Cav2.1 (P/Q-Type) calcium channelsJ Neurosci20173792485250328167673
   PubMed Web of Science ®Google Scholar
• ZhouXWangWZhangSCACNA1B (Cav2.2) overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in non-small cell lung cancerDis Markers2017201761364016136401828127114
   PubMed Web of Science ®Google Scholar
• TsouWLSoongBWPaulsonHLRodríguez-LebrónESplice isoform-specific suppression of the Cav2.1 variant underlying spinocerebellar ataxia type 6Neurobiol Dis201143353354221550405
   PubMed Web of Science ®Google Scholar
• HarkinsABCahillALPowersJFTischlerASFoxAPDeletion of the synaptic protein interaction site of the N-type (CaV2.2) calcium channel inhibits secretion in mouse pheochromocytoma cellsProc Natl Acad Sci U S A200410142152191522415471993
   PubMed Web of Science ®Google Scholar
• ElsheikhSEGreenARRakhaEACaveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeBr J Cancer200899232733418612310
   PubMed Web of Science ®Google Scholar
• SavageKLeungSToddSKDistribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysisBreast Cancer Res Treat2008110224525617912630
   PubMed Web of Science ®Google Scholar
• SagaraYMimoriKYoshinagaKClinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancerBr J Cancer200491595996515305200
   PubMed Web of Science ®Google Scholar
• SugieSMukaiSYamasakiKKamibeppuTTsukinoHKamotoTSignificant association of Caveolin-1 and Caveolin-2 with prostate cancer progressionCancer Genomics Proteom2015126391396
   Web of Science ®Google Scholar
• LiuXWangJSunGIdentification of key genes and pathways in renal cell carcinoma through expression profiling dataKidney Blood Press Res201540328829726043775
   PubMed Web of Science ®Google Scholar
• ZhangXZhangYMiaoYZhouHJiangGWangETMEM17 depresses invasion and metastasis in lung cancer cells via ERK signaling pathwayOncotarget2017841706857069429050311
   PubMedGoogle Scholar
• MengFLiuHLiuSMaRThe clinical significance of HPIP and the associated prognosis in cervical cancerOncotarget2017841702627027029050277
   PubMedGoogle Scholar
• XuHFuSChenQThe function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancerOncotarget2017819312153122628415720
   PubMedGoogle Scholar
• JingsongHHongGYangJsiRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migrationOncotarget2017822585259327906681
   PubMedGoogle Scholar
• WuHBiJPengYNuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancerOncotarget2017833543645437728903348
   PubMedGoogle Scholar
• XueMQLiuJSangJFSuLYaoYZExpression characteristic of CXCR1 in different breast tissues and the relevance between its expression and efficacy of neo-adjuvant chemotherapy in breast cancerOncotarget2017830489304893728454081
   PubMedGoogle Scholar
• LiYJinLYeFIsoform expression patterns of EPHA10 protein mediate breast cancer progression by regulating the E-cadherin and β-catenin complexOncotarget2017818303443035628427223
   PubMedGoogle Scholar
• LeeALeeSHJungCKUse of the Ion AmpliSeq Cancer Hotspot Panel in clinical molecular pathology laboratories for analysis of solid tumours: with emphasis on validation with relevant single molecular pathology tests and the Oncomine Focus AssayPathol Res Pract2018214571371929615338
   PubMed Web of Science ®Google Scholar
• YeLLiHZhangFLvTLiuHSongYExpression of KIF23 and its prognostic role in non-small cell lung cancer: analysis based on the data-mining of oncomineZhongguo Fei Ai Za Zhi2017201282282629277180
   PubMedGoogle Scholar
• XuBLiuNChenSQExpression of SRD5A1 and its prognostic role in prostate cancer: analysis based on the data-mining of ONCOMINEZhonghua Nan Ke Xue201622977177629071871
   PubMedGoogle Scholar
• LiuYJangSXieLSowaGHost deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesisCancer Res201474226452646225269481
   PubMed Web of Science ®Google Scholar
• AndoTIshiguroHKimuraMThe overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinomaOncol Rep200718360160917671707
   PubMed Web of Science ®Google Scholar
• LeeSKwonHJeongKPakYRegulation of cancer cell proliferation by caveolin-2 down-regulation and re-expressionInt J Oncol20113851395140221373752
   PubMed Web of Science ®Google Scholar
• DorđevićGMatušan IlijašKHadžisejdićIMaričićAGrahovacBJonjićNEGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinomaJ Biomed Sci2012194022475688
   PubMed Web of Science ®Google Scholar
• LiangLLiLZengJInhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathwayOncol Rep2012283999100522736024
   PubMed Web of Science ®Google Scholar
• diJGaoKQuDYangJZhengJRap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinomaTumour Biol2017397 1010428317701653
   Google Scholar
• ZhaoZLiuHHouJTumor protein D52 (TPD52) inhibits growth and metastasis in renal cell carcinoma cells through the PI3K/Akt signaling pathwayOncol Res201725577377927983909
   PubMed Web of Science ®Google Scholar
• ZhangHShengLTaoJDepletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathwayInt J Oncol20164962498250627779645
   PubMed Web of Science ®Google Scholar
• GuoHGermanPBaiSThe PI3K/AKT pathway and renal cell carcinomaJ Genet Genomics201542734335326233890
   PubMed Web of Science ®Google Scholar
• SunZCaoBWuJProtease-activated receptor 2 enhances renal cell carcinoma cell invasion and migration via PI3K/AKT signaling pathwayExp Mol Pathol201598338238925773677
   PubMed Web of Science ®Google Scholar